TMDX 240920 160.00C (TMDX240920C160000) Stock Options, News & Quotes

19.20
+0.20+1.05%

15min DelayClose Aug 23 16:00 ET

19.20High19.20Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

ROM-STAR

May 27 08:03

Owning stocks isn't enough -- you must understand what these companies do. If you can't summarize their business in one sentence, you might not truly know them.
Here are the one-liners for each stock in my portfolio 🧐
1. $CrowdStrike (CRWD.US)$ | Crowdstrike
• Their Falcon platform uses artificial AI and cloud technology to detect and respond to cyber threats by offering endpoint security, threat intelligence, and cyberattack response services.
2. $Snowflake (SNOW.US)$ | Snowflake
• A cloud-...

Pongz

May 1 00:31

$TransMedics (TMDX.US)$ more than 13% increase duruing post-market is unbelievable.

Moomoo AI

Mar 11 09:53

TransMedics Group's trend of growing ROCE and increasing capital employed suggests profitable reinvestment opportunities, potentially leading to a multi-bagger performance. The stock's solid return to shareholders over the last three years indicates investor recognition of these changes.

The Return Trends At TransMedics Group (NASDAQ:TMDX) Look Promising

Rockyturki

Mar 10 22:19

$Advanced Micro Devices (AMD.US)$ was obvious to buy at $100 and many waited
$Celsius Holdings (CELH.US)$ at $48 (this year) was the easiest money and people waited.
$Palantir (PLTR.US)$ at $14 was extremely undervalued and many waited
$Meta Platforms (META.US)$ was obvious to buy at $200 and everyone waited
$CrowdStrike (CRWD.US)$ was a clear buy at $150 and people waited
$TransMedics (TMDX.US)$ at $38 with a market cap of $1 Billion was a steal and nobody wanted to buy it.
Focus on the essentials: align...

Kevin Travers

Feb 27 10:02

Columns Biotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...